Barry Ticho, CHIEF MEDICAL OFFICER at Stoke Therapeutics, Inc. (STOK), sold 1,051 shares at $26.16 ($27K) on 2026-10-01, disclosed to the SEC on 2026-10-02.
Scheduled sale ($27k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| STOK | SELL | 2026-08-05 | $208K | — | Filing → |
| STOK | SELL | 2026-07-06 | $236K | — | Filing → |
| STOK | SELL | 2026-06-03 | $55K | — | Filing → |